Monday, March 10, 2025

Healthcare

Safe Supply Streaming Co Ltd. Partners with Greenlane to Revolutionize Drug Detection and Wellness Testing (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) 

Safe Supply Streaming Co Ltd. (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) ("Safe Supply" or "the Company") is a publicly-traded company that specializes in the acquisition, investment,...

OS Therapies Pioneers Hope for Osteosarcoma Patients 

OS Therapies is advancing therapies focused on HER-2 positive osteosarcoma, addressing a critical unmet need. The company draws inspiration from "Osteo-Angels," individuals whose battles against...

OSTX’s OST-HER2: A Potential Game-Changer for Osteosarcoma (NYSE-A: OSTX)

ROCKVILLE, Md. & NEW YORK, August 02, 2024--(BUSINESS WIRE)--OS Therapies Incorporated ("OS Therapies" or the "Company") (NYSE-A: OSTX), a Cancer Immunotherapy and Antibody Drug Conjugate...

OS Therapies Leading the Way to Breakthroughs in Cancer Treatment

OS Therapies focuses on developing advanced treatments for osteosarcoma, addressing a significant unmet medical need. With an estimated $1.72 billion market for osteosarcoma and a...

NurExone Biologics: Promising Future in Regenerative Medicine

NurExone Biologics is developing exosome-based therapies for non-invasive treatment of central nervous system injuries, with their lead product, ExoPTEN, showing significant promise in preclinical...

Popular

Subscribe